Cambridge, 5th, June 2025 – Clearview Market Insights (CVMI) forecasts that the global apoptosis assay market will expand from USD 3.4 billion in 2024 to USD 7.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 10.7 percent. The market's expansion is driven by oncology-focused drug discovery, increasing research into neurodegeneration, and the growing adoption of...
